Delay in commencing treatment for MDR TB at a specialised TB treatment centre in KwaZulu-Natal
Aim. This study aimed to assess the delay in the initiation of MDR TB treatment and profiled the patients being referred to a specialised drug-resistant treatment centre in KwaZulu-Natal.
Results. Of all the patients, 75% referred showed a mean delay of 12.4 weeks from the date of sputum collection for culture and drug sensitivity testing to the start of treatment. Most of the patients were symptomatic for TB and HIV-positive.
Discussion. Our findings suggest that current policy on the initiation of effective treatment needs urgent revision. Staff should be appropriately trained in LPA and GX technology to reduce delays in initiating treatment for MDR TB. The NDoH’s plans for rapid diagnosis and reducing the treatment burden on centralised MDR TB management facilities are in the early phases of implementation and will take years to achieve favourable and significant outcomes.
Conclusion. There is a significant delay in initiating definitive management for MDR TB.
R Narasimooloo, Department of Family Medicine, University of KwaZulu-Natal and Medical Research Council TB Unit, Durban
A Ross, Department of Family Medicine, University of KwaZulu-Natal and Medical Research Council TB Unit, Durban
Cite this article
Date published: 2012-05-08
Full text views: 3564